BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21484256)

  • 1. An emerging model for BAP1's role in regulating cell cycle progression.
    Eletr ZM; Wilkinson KD
    Cell Biochem Biophys; 2011 Jun; 60(1-2):3-11. PubMed ID: 21484256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.
    Machida YJ; Machida Y; Vashisht AA; Wohlschlegel JA; Dutta A
    J Biol Chem; 2009 Dec; 284(49):34179-88. PubMed ID: 19815555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.
    Yu H; Mashtalir N; Daou S; Hammond-Martel I; Ross J; Sui G; Hart GW; Rauscher FJ; Drobetsky E; Milot E; Shi Y; Affar el B
    Mol Cell Biol; 2010 Nov; 30(21):5071-85. PubMed ID: 20805357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression and E2F1-responsive gene expression via association with host cell factor-1 (HCF-1).
    Zhou P; Wang Z; Yuan X; Zhou C; Liu L; Wan X; Zhang F; Ding X; Wang C; Xiong S; Wang Z; Yuan J; Li Q; Zhang Y
    J Biol Chem; 2013 Jun; 288(24):17532-43. PubMed ID: 23629655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.
    Misaghi S; Ottosen S; Izrael-Tomasevic A; Arnott D; Lamkanfi M; Lee J; Liu J; O'Rourke K; Dixit VM; Wilson AC
    Mol Cell Biol; 2009 Apr; 29(8):2181-92. PubMed ID: 19188440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.
    Pan H; Jia R; Zhang L; Xu S; Wu Q; Song X; Zhang H; Ge S; Xu XL; Fan X
    Int J Biochem Cell Biol; 2015 Mar; 60():176-84. PubMed ID: 25582751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.
    Tyagi S; Chabes AL; Wysocka J; Herr W
    Mol Cell; 2007 Jul; 27(1):107-19. PubMed ID: 17612494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.
    Okino Y; Machida Y; Frankland-Searby S; Machida YJ
    J Biol Chem; 2015 Jan; 290(3):1580-91. PubMed ID: 25451922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the HCF-1 basic region in sustaining cell proliferation.
    Mangone M; Myers MP; Herr W
    PLoS One; 2010 Feb; 5(2):e9020. PubMed ID: 20126307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.
    Tyagi S; Herr W
    EMBO J; 2009 Oct; 28(20):3185-95. PubMed ID: 19763085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
    Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
    Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host cell factor-1 and E2F4 interact via multiple determinants in each protein.
    Knez J; Piluso D; Bilan P; Capone JP
    Mol Cell Biochem; 2006 Aug; 288(1-2):79-90. PubMed ID: 16633736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAP1 loss defines a new class of renal cell carcinoma.
    Peña-Llopis S; Vega-Rubín-de-Celis S; Liao A; Leng N; Pavía-Jiménez A; Wang S; Yamasaki T; Zhrebker L; Sivanand S; Spence P; Kinch L; Hambuch T; Jain S; Lotan Y; Margulis V; Sagalowsky AI; Summerour PB; Kabbani W; Wong SW; Grishin N; Laurent M; Xie XJ; Haudenschild CD; Ross MT; Bentley DR; Kapur P; Brugarolas J
    Nat Genet; 2012 Jun; 44(7):751-9. PubMed ID: 22683710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the tumor suppressor BAP1 causes myeloid transformation.
    Dey A; Seshasayee D; Noubade R; French DM; Liu J; Chaurushiya MS; Kirkpatrick DS; Pham VC; Lill JR; Bakalarski CE; Wu J; Phu L; Katavolos P; LaFave LM; Abdel-Wahab O; Modrusan Z; Seshagiri S; Dong K; Lin Z; Balazs M; Suriben R; Newton K; Hymowitz S; Garcia-Manero G; Martin F; Levine RL; Dixit VM
    Science; 2012 Sep; 337(6101):1541-6. PubMed ID: 22878500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.
    Arenzana TL; Lianoglou S; Seki A; Eidenschenk C; Cheung T; Seshasayee D; Hagenbeek T; Sambandam A; Noubade R; Peng I; Lesch J; DeVoss J; Wu X; Lee WP; Caplazi P; Webster J; Liu J; Pham VC; Arnott D; Lill JR; Modrusan Z; Dey A; Rutz S
    Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29678836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAP1 is phosphorylated at serine 592 in S-phase following DNA damage.
    Eletr ZM; Yin L; Wilkinson KD
    FEBS Lett; 2013 Dec; 587(24):3906-11. PubMed ID: 24211834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.
    Fukuda T; Tsuruga T; Kuroda T; Nishikawa H; Ohta T
    Curr Cancer Drug Targets; 2016; 16(2):101-9. PubMed ID: 26517537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer.
    Tsuboyama N; Wang R; Szczepanski AP; Chen H; Zhao Z; Shi L; Wang L
    Oncogene; 2022 Apr; 41(15):2152-2162. PubMed ID: 35194152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of host cell factor-1 in cell cycle regulation.
    Zargar Z; Tyagi S
    Transcription; 2012; 3(4):187-92. PubMed ID: 22771988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The THAP-zinc finger protein THAP1 associates with coactivator HCF-1 and O-GlcNAc transferase: a link between DYT6 and DYT3 dystonias.
    Mazars R; Gonzalez-de-Peredo A; Cayrol C; Lavigne AC; Vogel JL; Ortega N; Lacroix C; Gautier V; Huet G; Ray A; Monsarrat B; Kristie TM; Girard JP
    J Biol Chem; 2010 Apr; 285(18):13364-71. PubMed ID: 20200153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.